Study Group on Death Rate at High CD4 Count in Antoretroviral-naïve patientsinfo:eu-repo/semantics/nonPublishe
<p>*Adjusted for baseline gender, CD4 count, clinical stage, viral load, and calendar period. **In o...
(1) Objective: To investigate changes in mortality rates and predictors of all-cause mortality as we...
<p>Predicted for women aged 30–45, starting ART with a CD4 count 100–199 cells/µl in 2004–2007, adva...
Whether people living with HIV who have not received antiretroviral therapy (ART) and have high CD4 ...
Summary Background Whether people living with HIV who have not received antiretroviral therapy (ART)...
<p>Mortality rates for men and women stratified by baseline CD4+ cell count and age.</p
Whether people living with HIV who have not received antiretroviral therapy (ART) and have high CD4 ...
<p><b>Notes:</b><sup>1</sup> Adjusted for age, gender, history of AIDS or TB, and time-updated viral...
<p>Mortality by CD4 cell count at baseline and ART use among HIV-infected subjects.</p
BACKGROUND: Whether people living with HIV who have not received antiretroviral therapy (ART) and ha...
OBJECTIVE: To determine the relationship between mortality risk and the CD4 cell response to antiret...
<p>Mortality by Latest CD4+ Cell Count and ART status for Phidisa Participants.</p
International audienceTo identify the risk factors associated with presentation for care with CD4 ce...
Background: Evidence exists that even at high CD4 counts, mortality among HIV-infected antiretrovira...
Background: Increased mortality among men on antiretroviral therapy (ART) has been documented but re...
<p>*Adjusted for baseline gender, CD4 count, clinical stage, viral load, and calendar period. **In o...
(1) Objective: To investigate changes in mortality rates and predictors of all-cause mortality as we...
<p>Predicted for women aged 30–45, starting ART with a CD4 count 100–199 cells/µl in 2004–2007, adva...
Whether people living with HIV who have not received antiretroviral therapy (ART) and have high CD4 ...
Summary Background Whether people living with HIV who have not received antiretroviral therapy (ART)...
<p>Mortality rates for men and women stratified by baseline CD4+ cell count and age.</p
Whether people living with HIV who have not received antiretroviral therapy (ART) and have high CD4 ...
<p><b>Notes:</b><sup>1</sup> Adjusted for age, gender, history of AIDS or TB, and time-updated viral...
<p>Mortality by CD4 cell count at baseline and ART use among HIV-infected subjects.</p
BACKGROUND: Whether people living with HIV who have not received antiretroviral therapy (ART) and ha...
OBJECTIVE: To determine the relationship between mortality risk and the CD4 cell response to antiret...
<p>Mortality by Latest CD4+ Cell Count and ART status for Phidisa Participants.</p
International audienceTo identify the risk factors associated with presentation for care with CD4 ce...
Background: Evidence exists that even at high CD4 counts, mortality among HIV-infected antiretrovira...
Background: Increased mortality among men on antiretroviral therapy (ART) has been documented but re...
<p>*Adjusted for baseline gender, CD4 count, clinical stage, viral load, and calendar period. **In o...
(1) Objective: To investigate changes in mortality rates and predictors of all-cause mortality as we...
<p>Predicted for women aged 30–45, starting ART with a CD4 count 100–199 cells/µl in 2004–2007, adva...
Add to ORKG